Clinical Trials
14 trialsNCT05020912 2026-06-01
Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy
Case Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT06608511 2026-05-29
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
University of Wisconsin, Madison
Active not recruiting
NCT05294120 2026-04-20
A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05724875 2026-03-27
LANCE
Centre Hospitalier Universitaire Vaudois
Phase NA Active not recruiting
NCT04744935 2026-03-24
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
University of California, Irvine
Phase NA Active not recruiting
NCT04616248 2026-01-07
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
Phase 1 Active not recruiting
NCT05935995 2025-11-28
HISTOBLOC
Institut de Cancérologie de Lorraine
Phase NA Active not recruiting
NCT05473507 2025-10-09
A Study of Observation and Follow-up in People With Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT05133427 2025-10-03
BCC-HIFU2101
Bispebjerg Hospital
Phase NA Active not recruiting
NCT07177638 2025-09-17
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
NYU Langone Health
Phase NA Active not recruiting
NCT06014619 2025-04-04
Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs
Maastricht University Medical Center
Active not recruiting
NCT05202860 2025-01-22
VAXAK
Bispebjerg Hospital
Phase 2 Active not recruiting
NCT06598137 2024-09-25
Study to Examine Lesions of the Skin Using Confocal Laser Microscopy
LMU Klinikum
Active not recruiting
NCT04679480 2024-07-30
Anti-PD1-antibody and Pulsed HHI for Advanced BCC
University of Zurich
Phase 2 Active not recruiting